Levodopa Concentration Profile With Stalevo 75/125 mg
Phase 1
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2010-02-18
- Last Posted Date
- 2010-08-13
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 20
- Registration Number
- NCT01070628
- Locations
- 🇫🇮
Phase I Unit, Orion Pharma, Espoo, Finland
Safety and Pharmacokinetic Study With Multiple Ascending Doses of ORM-12741
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 49
- Registration Number
- NCT01068028
- Locations
- 🇫🇷
Forenap Pharma, Rouffach, France
Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers
Not Applicable
Completed
- Conditions
- AsthmaPulmonary Disease, Chronic Obstructive
- Interventions
- Other: Empty inhalers
- First Posted Date
- 2009-09-25
- Last Posted Date
- 2010-06-08
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 200
- Registration Number
- NCT00984906
- Locations
- 🇫🇮
Skin and Allergy hospital, Helsinki, Finland
🇫🇮Jorvi hospital, Helsinki, Finland
🇬🇧Northern General Hospital, Sheffield, United Kingdom
Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2010-02-15
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 87
- Registration Number
- NCT00964535
- Locations
- 🇬🇧
Medicines Evaluation Unit, Manchester, United Kingdom
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets
- First Posted Date
- 2009-04-09
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 18
- Registration Number
- NCT00878865
- Locations
- 🇫🇮
Orion Pharma phase I unit, Espoo, Finland
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions
- First Posted Date
- 2009-04-09
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 18
- Registration Number
- NCT00878514
- Locations
- 🇫🇮
Orion Pharma Phase I unit, Espoo, Finland
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Budesonide/Formoterol Batch 1Drug: Budesonide/Formoterol Batch 2Drug: Budesonide/Formoterol Batch 1 and charcoal
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2009-08-13
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 12
- Registration Number
- NCT00868426
- Locations
- 🇫🇮
Orion Pharma Phase I Unit, Espoo, Finland
Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis
Phase 4
Completed
- Conditions
- Dermatitis, Atopic
- Interventions
- Other: Aqualan L, Aqualan Plus, Aqualan L + glycerol ad 20%
- First Posted Date
- 2009-02-18
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT00846235
- Locations
- 🇫🇮
Orion Pharma R&D, Espoo, Finland
Early Phase I Microdosing Study of ORM-14540 and ORM-12741
- First Posted Date
- 2009-01-28
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 6
- Registration Number
- NCT00831077
- Locations
- 🇫🇮
CRST, Turku, Finland
A PET Study With ORM-12741
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2009-11-25
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 26
- Registration Number
- NCT00829907
- Locations
- 🇫🇮
Turku PET centre, Turku, Finland
© Copyright 2025. All Rights Reserved by MedPath